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E-mail address: rduncan@york.cuny.edu (R.O. DunPurpose: Altered metabolic activity has been identiﬁed as a potential contributing factor to the neurode-
generation associated with primary open angle glaucoma (POAG). Consequently, we sought to determine
whether there is a relationship between the loss of visual function in human glaucoma and resting blood
perfusion within primary visual cortex (V1).
Methods: Arterial spin labeling (ASL) functional magnetic resonance imaging (fMRI) was conducted in 10
participants with POAG. Resting cerebral blood ﬂow (CBF) was measured from dorsal and ventral V1.
Behavioral measurements of visual function were obtained using standard automated perimetry (SAP),
short-wavelength automated perimetry (SWAP), and frequency-doubling technology perimetry (FDT).
Measurements of CBF were compared to differences in visual function for the superior and inferior hemi-
ﬁeld.
Results: Differences in CBF between ventral and dorsal V1 were correlated with differences in visual func-
tion for the superior versus inferior visual ﬁeld. A statistical bootstrapping analysis indicated that the
observed correlations between fMRI responses and measurements of visual function for SAP (r = 0.49),
SWAP (r = 0.63), and FDT (r = 0.43) were statistically signiﬁcant (all p < 0.05).
Conclusions: Resting blood perfusion in human V1 is correlated with the loss of visual function in POAG.
Altered CBF may be a contributing factor to glaucomatous optic neuropathy, or it may be an indication of
post-retinal glaucomatous neurodegeneration caused by damage to the retinal ganglion cells.
 2012 Elsevier Ltd. All rights reserved.1. Introduction
The glaucomas, the second leading cause of worldwide blind-
ness, are a group of progressive optic neuropathies that are charac-
terized by a gradual loss of retinal ganglion cells and a progressive
neurodegeneration of the optic nerve. Left untreated, there can be
irreversible vision loss and eventual blindness. Although elevated
intraocular pressure is a leading risk factor, the pathophysiology
of the neuronal degeneration of the glaucomas remains unknown.
Several factors other than altered intraocular pressure have been
identiﬁed as potentially contributing to the disease (Weinreb &
Khaw, 2004), including alterations in ocular perfusion and altera-
tions in the ocular and systemic microcirculation (Harris, 2009).
In addition to the retinal ganglion cells, the glaucomas also can
have damage to post-retinal mechanisms, including the lateral
geniculate nucleus of the thalamus (LGN) and the primary visual
cortex (V1). Neuronal degeneration of the LGN and activity changes
in V1 have been discovered using experimental models of glau-
coma in primates (Crawford et al., 2000, 2001; Vickers et al.,ll rights reserved.
can).1997; Weber et al., 2000; Yucel et al., 2000, 2001, 2003). Metabolic
activity is also greatly reduced within V1 ocular dominance col-
umns that receive input from the glaucomatous eye (Brooks
et al., 2004; Crawford et al., 2000, 2001).
Neuroimaging methods have been used to monitor glaucoma-
tous changes in human brain morphology and function in vivo
(Duncan, 2010). Studies using traditional MRI methods (e.g.,
T1-weighted imaging) have reported a decrease in the volume of
anatomically distinct visual areas including the optic nerve, LGN,
and V1 in human glaucoma (Boucard et al., 2009; Brodsky, Glasier,
& Creel, 1993; Fujita et al., 2001; Gupta et al., 2009; Iwata et al.,
1997; Kashiwagi, Okubo, & Tsukahara, 2004; Kitsos et al., 2009;
Lagreze et al., 2009). Diffusion tensor imaging has also been used
to measure glaucomatous degeneration of the optic nerve (Garcia,
de Bazelaire, & Alsop, 2005; Xu et al., 2008). While anatomical
imaging techniques have proven useful for quantifying cortical
thickness and volume in post-retinal structures, these methods
are limited because they cannot measure neuronal function or
blood ﬂow, which may be better indicators of the neuropathology
of the glaucomas. Furthermore, anatomical techniques are not
ideal for comparing cortical data to visual function data because
regions of interest within visual cortex can only be localized
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used to localize regions of interest throughout V1 (Duncan et al.,
2007a, 2007b), which is important considering the variability of vi-
sual areas between individuals (Duncan & Boynton, 2003).
While the traditional blood oxygen level dependent (BOLD)
fMRI technique is preferred for deﬁning regions of interest in the
brain based on neuronal activity, it is difﬁcult to measure glauco-
matous neurodegeneration using BOLD. Visual stimulation must
be used to elicit neuronal activity in BOLD experiments. Therefore,
it is difﬁcult to differentiate whether a reduction in the cortical
fMRI signal of glaucoma patients is due to cortical neurodegenera-
tion or damage to the optic disk. Furthermore, the BOLD technique
measures the relative change in neuronal activity associated with
two brain states, and therefore BOLD does not directly measure
ischemic injury in quantitative units.
Arterial spin labeling (ASL) is a non-invasive MRI method that
measures absolute CBF in ml/100 g/min (Detre et al., 1992). ASL
can measure resting CBF in the absence of visual stimulation. Com-
pared to the BOLD technique, ASL demonstrates less inter-subject
variability, and ASL tends to be more robust in the presence of
baseline vascular changes (Aguirre et al., 2002; Brown et al.,
2003; Stefanovic et al., 2006; Tjandra et al., 2005; Wang et al.,
2003). It also has been suggested that the ASL signal may be more
localized to brain parenchyma than BOLD (Kim, 1995; Luh et al.,
2000). Therefore, ASL is a better choice for measuring the resting
perfusion state of brain tissue in human glaucoma.
The objective of this study was to compare ASL fMRI measure-
ments of CBF from V1 to standard measures of visual function in
human primary open angle glaucoma, the most prevalent of the
glaucomas.2. Methods
2.1. Subjects
Participants with primary open angle glaucoma (POAG) were
selected from the ongoing longitudinal Diagnostic Innovations in
Glaucoma Study (DIGS), conducted at the Hamilton Glaucoma Cen-
ter at the University of California at San Diego (UCSD). The DIGS
study is prospectively designed to assess structure and function
in glaucoma. Informed consent was obtained from all participants
after the nature and procedures of the study were explained. The
Institutional Review Board of the University of California at San
Diego approved the study, which follows the tenets of the Declara-
tion of Helsinki.2.1.1. Inclusion criteria for DIGS
Participants underwent complete ophthalmologic examinations
including slitlamp biomicroscopy, intraocular pressure measure-
ment, and dilated stereroscopic fundus examination. Simultaneous
stereoscopic photographs were obtained for all participants and
had to be of adequate quality for the subject to be included. All par-
ticipants had open angles, a best corrected acuity of 20/40 or better,
a spherical refraction within and inclusive of ±5.0 D (transposition
allowed), and cylinder correction within ±3.0 D. A family history
of glaucoma was allowed.2.1.2. Exclusion criteria for DIGS
We excluded all participants with non-glaucomatous secondary
causes of elevated intraocular pressure (IOP) (e.g., iridocyclitis,
trauma), other intraocular eye disease, other diseases affecting
the visual ﬁeld (e.g., pituitary lesions, demyelinating diseases,
HIV+ or AIDS, or diabetic retinopathy), with medications known
to affect visual ﬁeld sensitivity, or with problems other than glau-coma affecting color vision (as assessed by the Farnsworth D-15
color vision test).
2.1.3. For this report
Glaucomatous optic neuropathy was deﬁned for this report
based on the appearance of a glaucomatous optic disk and by a
repeatable abnormal SAP result in at least one eye. Ten participants
with reliable visual ﬁeld results on three tests of visual function
were included from DIGS. Reliable visual ﬁelds were deﬁned as
625% false positives, false negatives, and ﬁxation losses. Partici-
pants also had a statistically signiﬁcant superior–inferior visual
hemiﬁeld asymmetry on at least two consecutive tests in one eye
for SAP, as indicated by the Glaucoma Hemiﬁeld Test in the StatPac
analysis package included with the visual ﬁeld analyzer (Carl Zeiss
Meditec, Dublin, CA). All tests of visual function were done in ran-
domized order and completed within a 3-month period. Partici-
pants were also screened for standard MRI exclusion criteria: no
conditions/medications known to affect cerebral metabolism, no
metal in the body that could not be removed, and no history of
claustrophobia. Participants were selected on the basis of consecu-
tive visual ﬁeld testing using the Glaucoma Hemiﬁeld Test and not
MR imaging.
2.2. Evaluation of stereophotographs
Evaluation of stereophotographs has been described in detail
elsewhere (Sample et al., 2006). Evaluation of structural damage
to the optic disk was based on assessment of simultaneous stereo-
scopic optic disk photographs (Nidek Stereo Camera Model 3-DX,
Nidek Inc, Palo Alto, CA). Two experienced graders evaluated the
photographs, and each grader was masked to the subject’s identity,
the other test results, and the other grade. All included photo-
graphs were judged to be of good quality. Discrepancies between
the two graders were resolved either by consensus or by a third
experienced grader. Glaucomatous optic disks were deﬁned as hav-
ing either asymmetric vertical cup-to-disk ratio >0.2, rim thinning,
notching, excavation, disk hemorrhages, or nerve ﬁber layer
defects.
2.3. Psychophysical tests of function
Visual ﬁelds were collected using SAP, SWAP, and FDT. Details
of these tests have been presented previously (Boden et al., 2005;
Martinez, Sample, & Weinreb, 1995; Racette & Sample, 2003;
Racette et al., 2008; Sample et al., 2006). All measurements were
conducted within the central 30 of the visual ﬁeld and required
ﬁxation by the participant. Proper refraction was provided for each
device. All tests required a 3 mm or larger pupil. Dilation was used
if necessary. Lids of eyes with potential ptosis were taped to reduce
artifacts. The untested eye was occluded with an eye patch.
2.3.1. SAP
SAP utilizes a small (0.47), 200-ms ﬂash of white light as the
target presented on a dim background (10 cd/m2 or 31.5 asb).
The target was randomly presented to 54 locations within the cen-
tral 24 of visual ﬁeld using a Humphrey Visual Field Analyzer II
(Carl Zeiss Meditec, Dublin, CA), which used the 24-2 protocol
(software version 3.4.7) and the Swedish Interactive Thresholding
Algorithm (SITA) testing algorithm. The two locations just above
and below the blind spot were not included in the analysis.
2.3.2. SWAP
SWAP was measured with the same perimeter, software ver-
sion, and protocol as SAP-SITA. SWAP utilizes a 440 nm, narrow
band, 1.8 target at 200-ms duration on a bright 100 cd/m2 yellow
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cones and their connections.
2.3.3. FDT
FDT perimetry (24-2) was measured on a commercially avail-
able device, the Matrix perimeter, which was developed by
Welch-Allyn (Skaneateles, NY) and marketed by Carl Zeiss Meditec.
The Matrix FDT uses the Zippy Estimation by Sequential Testing
(ZEST) thresholding algorithm (Turpin et al., 2002). FDT measures
the contrast required to detect a counterphase ﬂickering grating
that spans 5 of visual angle. The sinusoidal grating has a spatial
frequency of 0.5 cyc/deg and a temporal frequency of 18 Hz.
2.3.4. Analyses and visualization of the visual ﬁeld data
Because area V1 receives binocular input, measurements of
resting CBF are predicted to correlate best with binocular visual
function. Consequently, the visual function data from each eye
were combined. Visual ﬁeld parameters were derived by compar-
ing each participant’s data to the manufacturer’s normative data-
base. For each participant, the pattern deviation (PD) values from
the left and right eye were averaged for each test location based
on their proximity to the center of ﬁxation. The PD values indicate
the deviation in decibels from the age-corrected normal values for
each test location within the visual ﬁeld. Increasingly negative PD
scores indicate a greater deviation from normal vision due to glau-
coma. PD values were selected rather than mean deviation (MD) or
total deviation (TD) values because they are a less sensitive but
more selective indicator of the pattern of vision loss associated
with glaucoma. The mean PD value for each test location was com-
pared to the normative database and a p-value was assigned
accordingly. The p-values served only to assist in the visualization
of the data. All subsequent data analysis was conducted using the
mean PD values. The two most eccentric nasal and temporal points
were included in our visualization of the data but not in the ﬁnal
statistical analysis.
2.4. General MRI methodology
Each subject participated in a single 1-h scanning session that
included anatomical, BOLD, and ASL scans. FMR images were ac-
quired at the Center for Functional Magnetic Resonance Imaging
at UCSD using a General Electric 3.0 Tesla HD Signa Excite scanner
with an 8-channel brain coil. Visual stimuli were presented using
ﬁber optic goggles (Avotec Inc., Stuart, FL). The general speciﬁca-
tions of the visual presentation system follow: ﬁeld of view = 30-
H  23 V degrees; focus ±6 D; maximum luminance = 28.9 cd/m2;
resolution = 1024H  768 V, 60 Hz refresh rate. Visual stimuli were
generated using the Psychophysics Toolbox (Brainard, 1997; Pelli,
1997) for Matlab (Mathworks, Natick, MA) on a MacBook Pro com-
puter (Apple, Cupertino, CA).
Standard anatomical and BOLD fMRI scanning protocols were
used to conduct retinotopic mapping in each participant. A high-
resolution (1  1  1 mm voxel) reference volume was obtained
for each subject using a T1-weighted, Fast Spoiled Gradient Echo
pulse sequence (FSPGR). Retinotopic mapping was obtained for
each subject using a low-bandwidth echo planar imaging (EPI)
pulse sequence lasting 260 s (TR = 2 s, TE = 30 ms, ﬂip angle = 90,
28 axial slices, FOV = 20  20 cm). The ﬁrst 10 temporal frames
(20 s) were discarded to avoid magnetic saturation effects.
Cortical ﬂattening techniques and methods for projecting func-
tional data onto a ﬂattened representation of visual cortex have
been described in detail elsewhere (Duncan & Boynton, 2003).
The occipital pole was ﬂattened initially, dorsal and ventral V1
were deﬁned using standard retinotopic analysis methods, and
V1 was re-ﬂattened to minimize local distortions caused by ﬂat-
tening. Regions of interest corresponding to dorsal and ventralV1 were redeﬁned within the ﬂattened representations. These re-
gions of interest were then projected back to the 3D reference vol-
ume. Finally, the anatomical images and regions of interest were
resampled to match the resolution of the ASL fMRI data.
2.5. Retinotopy stimuli
Standard retinotopic mapping was conducted to delineate the
borders of dorsal and ventral V1. The details of this procedure have
been described elsewhere (Duncan et al., 2007a, 2007b). During
retinotopic mapping, participants viewed binocular images of
either an expanding ring or a rotating wedge made from con-
trast-reversing checkerboards (100% contrast; 8 Hz ﬂicker). In
addition to the rings and wedges, the horizontal and vertical
meridians were mapped using alternating ‘‘hourglass’’ and ‘‘bow
tie’’ shaped checkerboard patterns. Meridian-mapping stimuli
were composed of two mirror-symmetric, triangular regions span-
ning 90 of polar angle about the meridian. The parameters of the
contrast-reversing checkerboards (1  1 squares, 8 Hz ﬂicker
freq., 100% contrast on a mean gray background) were selected
from values known to elicit a maximum BOLD response from V1
(DeYoe et al., 1994; Engel, Glover, & Wandell, 1997; Engel et al.,
1994; Sereno et al., 1995; Tootell et al., 1998).
Eye movements were monitored via an infrared camera in the
visual presentation system (iView dark-pupil eye tracking soft-
ware, SMI, Teltow, Germany). Eye traces were processed according
to previously developed protocols (Krauzlis & Miles, 1996). Devia-
tions in eye position beyond 3 deg of visual angle were ﬂagged.
Analysis revealed that the direction of ﬁxation breaks was spatially
distributed and not associated with viewing through the glauco-
matous or fellow eye (v2, all p > 0.10). It is important to note that
ﬁxation losses only add noise to the fMRI signal during retinotopic
mapping. Thus, ﬁxation losses cannot account for a correlation be-
tween visual function loss and measurements of CBF, which were
obtained in the absence of visual stimulation.
2.6. ASL methodology
2.6.1. Data acquisition
Measurements of CBF were obtained using a modiﬁed ﬂow-sen-
sitive inversion recovery (FAIR) pulse sequence with single-shot
spiral read out (Wong, Buxton, & Frank, 1998). Twenty contiguous
axial slices were collected from V1 (5  5 mm resolution and 1 mm
spacing). Three scans were used: The ASL-FAIR scan collects perfu-
sion-weighted data, and the CSF and MinContrast scans are re-
quired to quantify the perfusion data. The global inversion pulse
in standard FAIR was replaced by a spatially selective inversion
pulse, which extended 10 cm in either direction outside the imag-
ing slab. A 200 mm tagging slab was placed 10 mm below the most
inferior slice. QUIPSS II saturation pulses were applied, and the TI1
and TI2 parameters were chosen to satisfy the following two crite-
ria (Wong, Buxton, & Frank, 1998): (1) TI1 is less than the natural
temporal bolus width d and (2) TI2–TI1 is greater than the longest
transit delayDt. The pulse sequence used a single shot spiral acqui-
sition, collecting 50 tag + control image pairs (TI1 = 600 ms,
TI2 = 1600 ms, TR = 2.5 s, TE = minimum, FOV = 22  22 cm). The
ASL-FAIR scan lasted 4 min 10 s and the two calibration scans
lasted 1 min each.
During each ASL scan, a dark cloth was used to cover the eyes of
the participants, and the room lights were attenuated so that par-
ticipants were not subjected to visible light. Because fMRI activity
in visual cortex is suppressed when the eyes are closed (Goldman
et al., 2002), participants were instructed to keep their eyes open
during the duration of the scan. Compliance was monitored using
an infrared camera within the eye tracking goggles. Because the
eye tracker uses infrared light, we were able to monitor eye
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ation-tolerance windowwas used in the iView software (20 visual
angle). Thus, participants could freely move their eyes in the dark,
but an alarm would sound if they closed their eyes for longer than
one second.
2.6.2. Data analysis
ASL data analysis methods have been described in detail else-
where (Lu et al., 2008). The ﬁrst four images of each scan were ex-
cluded to avoid magnetic saturation effects. Each ASL scan was
motion corrected and then registered to the ﬁrst functional run
using AFNI software (Cox, 1996). Functional scans were aligned to
the anatomical volume using the scanner coordinates of each vol-
ume. CBF responses were computed by subtracting the control
and tag image series. If odd indices correspond to control images
and even indices correspond to tag images, then the surround sub-
traction over an image acquisition time series y[n], n = 0,1,2,. . .pro-
duces the perfusion weighted time series: {y[1]  (y[0] + y[2])/2,
(y[1] + y[3])/2  y[2],. . .} (Liu & Wong, 2005). Mean CBF was com-
puted for voxels within the regions of interest corresponding to
dorsal and ventral V1. The mean CBF for each voxel was averaged
across four scans in the same fMRI scanning session for each
participant.
2.6.3. Comparing measurements of CBF to visual ﬁelds
Measurements of resting CBF from V1 were compared to mea-
surements of visual function obtained with SAP, SWAP and FDT.
For each test of visual function, difference scores (DPDMEAN) were
computed, one for the left and right hemiﬁeld, to reveal any asym-
metry that might exist between the superior versus inferior quad-
rants. Thus, each participant generated six DPDMEAN values, two
for each test of visual function. DPDMEAN was computed by sub-
tracting the mean of all PD values in the inferior visual quadrant
from the mean of the superior quadrant. Positive DPDMEAN values
indicate better visual function for the superior versus inferior visual
quadrant. Negative DPDMEAN values indicate better visual function
for the inferior visual quadrant. The mean resting CBF was com-
puted for voxels within dorsal and ventral V1. Difference scores
(DCBFMEAN) were computed for each hemisphere by subtracting
the mean dorsal CBF from the mean ventral CBF. PositiveDCBFMEAN
values indicate greater resting CBF for ventral versus dorsal V1 in
each hemisphere. PD and CBF difference scores for both hemi-
spheres in all participants were compared using simple linear
regression.3. Results
3.1. Data from a single subject
Visual ﬁeld data for participant 4 are presented in Fig. 1. Data
from SAP, SWAP and FDT are presented in each row. Data from
the right and left eyes are presented in the two left columns. Data
in the right column indicate the average PD value across both eyes
for each test location. The data for each test location is shaded to
indicate the PD (or mean PD) value in dB. The legend indicates
how these measurements compare to data from the normative
database for each test. The p-values serve only to make this presen-
tation of the data intuitive to those accustomed to viewing print-
outs from standard perimeters. The mean PD values for SAP,
SWAP and FDT denote that this participant had severe visual loss
in the inferior hemiﬁeld of the left eye. Statistical bootstrapping re-
vealed that the asymmetry was signiﬁcant for each test (all
p < 0.05). It is important to note, however, that a signiﬁcant asym-
metry for all three tests of visual function was not a necessary cri-
terion for inclusion in this study.CBF data for participant 4 are presented in Fig. 2. Anatomical
images for several axial slices through V1 are displayed in each pa-
nel using a grayscale map. The color map superimposed upon the
anatomical images indicates the CBF values for active voxels in
ml/100 g/min. Each row of panels is composed of axial slices that
contained active voxels for dorsal and ventral V1 in either hemi-
sphere. The data indicate that resting CBF for participant 4 is great-
er in ventral V1 compared to dorsal V1. This asymmetry in CBF is
consistent with the asymmetry in visual function observed in
Fig. 1. The relative loss of visual function in the inferior hemiﬁeld
of participant 4 is accompanied by a relative decrease in CBF within
dorsal V1.
3.2. Measurements of CBF correlate with visual function
Data for superior and inferior visual ﬁelds and dorsal and ven-
tral cortex appear in Table 1. Visual ﬁeld data for both eyes (OU)
and CBF measurements from V1 are presented for all 10 partici-
pants in Fig. 3. Yellowish-red pixels correspond to voxels where
measurements of resting CBF were relatively large. Bluish-purple
pixels indicate relatively smaller measurements of CBF. To con-
serve space, the axial slice with the highest mean CBF value is pre-
sented for each region of interest. However, data analysis was
conducted on all active voxels within dorsal and ventral V1.
Measurements of CBF were compared to visual ﬁelds for all par-
ticipants (Fig. 4). Each data point represents the asymmetry in vi-
sual ﬁelds (DPDMEAN) and CBF (DCBFMEAN). There was a positive
correlation between DPDMEAN and DCBFMEAN for SAP (r = 0.49;
p < 0.05) and SWAP (r = 0.63; p < 0.05). There was a borderline sig-
niﬁcant correlation (r = 0.43; p = 0.059) between DCBFMEAN and
DPDMEAN for FDT. While deﬁnitive conclusions cannot be based
on this analysis for FDT, the consistency between the three tests
of visual function is notable. Speciﬁcally, participants with large
superior–inferior visual ﬁeld asymmetries also possessed large dif-
ferences in CBF measurements from ventral versus dorsal V1, and
vice versa. Simple linear regression did not reveal a correlation be-
tween mean CBF and age (r = 0.21, F(1,8) = 0.39, p = 0.55).
There was relatively low power to detect an association be-
tween DCBFMEAN and DCBFMEAN for FDT due to the small number
of subjects enrolled in the study. Consequently, a statistical ‘‘boot-
strapping’’ method was used to determine whether the correla-
tions observed between CBF responses and visual ﬁelds was
signiﬁcant (Henderson, 2005; Hesterberg et al., 2005). Statistical
bootstrapping is well suited to small samples sizes because it re-
duces the assumptions made regarding the population distribu-
tion. The DCBFMEAN for a given hemisphere was randomly paired
with the DPDMEAN from another subject. For each sample of ran-
dom pairings, a correlation coefﬁcient was computed. This process
was repeated 10,000 times. To determine the statistical signiﬁ-
cance (i.e., p-value) of the originally observed correlation statistic,
the number of randomly generated correlations that exceeded the
observed correlation statistic was divided by the total number of
random correlations. The bootstrapping approach reveals that
DCBFMEAN was signiﬁcantly correlated with DPDMEAN for FDT as
well as for SAP and SWAP (all p < 0.05).
The bootstrapping approachwas also used to determinewhether
the observed correlations could be attributed to between-subject
variability rather than within-subject, retinotopic differences in vi-
sual function. TheDCBFMEAN values fromeach region of interest (i.e.,
dorsal-left (DL), dorsal-right (DR), ventral-left (VL) and ventral-right
(VR)) were randomly paired with theDPDMEAN values from each vi-
sual quadrant for each participant. For each sample of random pair-
ings, a correlation coefﬁcient was computed. This process was
repeated 10,000 times and a p-value was computed. For all three
tests of visual function, the observed correlations between
DCBFMEAN and DPDMEAN were signiﬁcantly greater than the
Fig. 1. Visual ﬁeld data for a single subject. SAP, SWAP and FDT data are presented for participant 4. Data from the right (OD) and left (OS) eyes are presented with the average
PD value (in dB) across both eyes (OU) for each test location. Shading and p-values indicate how data compare to standard normative databases obtained from monocular
viewing. Participant 4 had severe visual loss in the inferior hemiﬁeld of the left eye (all p < 0.05).
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likely that between-subject variability could account for the ob-
served correlations, and CBF is correlated with visual function at
the level of retinotopy.4. Discussion
There are few studies of cortical metabolism or cerebral blood
ﬂow in the human glaucomas (Duncan, 2010). To our knowledge,
the current report is the ﬁrst to quantify the relationship between
measurements of visual ﬁeld loss and resting cortical blood perfu-
sion in human glaucoma. CBF was relatively lower for regions of V1
that correspond to glaucomatous regions of the visual ﬁeld. The re-
sults from this study suggest that the ASL fMRI can be used to mea-
sure CBF throughout the visual system in human glaucoma, and
cortical metabolism is likely to be affected in human POAG. It is
recognized, however, that a causal relationship between glaucoma
and decreased CBF cannot be established without a control group
that demonstrates visual ﬁeld loss not resulting from glaucoma.
Future studies will compare CBF in patients with glaucoma to
patients with Ischemic Optic Neuropathy (ION).4.1. Measurement of metabolism and blood ﬂow in human glaucoma
The experimental glaucomas may stem from different etiologies
than human glaucoma. Consequently, human studies are preferred
to determine the contribution of metabolism and blood ﬂow to
POAG. There is a large body of data obtained from fundus imaging
techniques that implicate ocular blood perfusion in glaucoma
(Flammer & Mozaffarieh, 2008; Grover & Budenz, 2011; He et al.,2011; Leske, 2009; Schmidl, Garhofer, & Schmetterer, 2011;
Venkataraman, Flanagan, & Hudson, 2010; Yanagi et al., 2011).
Fundus imaging techniques can measure blood ﬂow via the pupil,
but these methods rely upon optical transparency and clear media.
Neuroimaging can be used to study anatomical structure and neu-
rovascular coupling throughout the visual pathway without such
limitations.
Previous neuroimaging studies have provided indirect evidence
for altered cerebral metabolism in glaucoma. T1-weighted MRI re-
veals that normal tension glaucoma patients have an increased
incidence of cerebral infarcts, white matter hyperintensities, sub-
cortical ischemia, and corpus collosum atrophy (Acaroglu, Kansu,
& Dogulu, 2001; Ong et al., 1995; Stroman et al., 1995). Decreased
visual function in various retinal pathologies was correlated with a
wider calcarine sulcus (Kitajima et al., 1997). Ischemic changes
throughout the brain correlate with decreased visual function in
normal tension glaucoma (Suzuki et al., 2004). And POAG patients
demonstrate optic nerve atrophy, degeneration of the optic chiasm
and V1, microvascular injury, and a higher concentration of white
matter hyperintensities in the cortex and optic chiasm (Kitsos
et al., 2009).
Single-voxel proton magnetic resonance spectroscopy (1H-MRS)
can detect concentrations of the metabolites N-acetylaspartate
(NAA), creatine (Cr), and choline (Cho), which are markers of neu-
ronal integrity, metabolism and cell death. Surprisingly, 1H-MRS
revealed normal metabolite concentrations (NAA, Cr, and Cho) in
V1 for patients with POAG (Boucard et al., 2007). Conversely, 1H-
MRS revealed abnormal metabolite concentrations in a rodent
model of glaucoma (Chan, So, & Wu, 2009). Cho levels were signif-
icantly lower in the glaucomatous regions of visual cortex com-
pared to healthy control regions. Chan and colleagues speculate
Fig. 2. CBF data for a single subject. Axial slices through V1 are displayed for Participant 4. The color map indicates CBF values for voxels in ml/100 g/min. CBF data was
constrained to the four regions of interest (dorsal-left (DL), dorsal-right (DR), ventral-left (VL) and ventral-right (VR)). Consistent with this participant’s asymmetry in visual
function, resting CBF in ventral V1 is greater than dorsal V1. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
Table 1
Subject data for measurements of visual function and CBF.
Subject Age SAP* SWAP* FDT* CBF**
Left Right Left Right Left Right Right Left
1 59 0.46 2.69 2.69 1.73 1.11 5.70 23.55 29.03
2 50 4.62 2.62 4.35 1.35 2.30 6.59 14.93 53.71
3 73 10.38 4.27 13.62 5.12 5.56 8.19 16.38 50.97
4 59 2.15 1.92 2.73 3.31 3.44 5.41 6.50 19.36
5 59 6.46 12.04 0.81 10.08 0.37 19.85 6.11 82.31
6 75 3.50 1.81 0.81 0.38 0.33 2.26 4.77 27.30
7 73 0.88 1.35 0.65 1.46 1.30 1.78 6.73 47.20
8 54 1.31 1.85 5.46 7.96 7.96 6.22 129.10 50.00
9 66 3.88 1.73 8.35 0.92 1.00 3.44 42.29 22.94
10 56 2.35 2.04 0.85 0.38 0.63 2.22 74.19 27.40
* DPD (dB) from left and right hemiﬁeld.
** DCBF (ml/100 g/min) from right and left hemisphere.
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in metabolites because of insufﬁcient ﬁeld strength. Metabolite
changes might have been too slow to detect, or the sample size
might have been too small to detect a difference.
Reduced cortical blood ﬂow was reported using 123I-IMP SPECT
in a 22-year-old patient with normal tension glaucoma (Yoshida
et al., 2006). The patient’s visual ﬁelds progressed without changes
to IOP. Seven out of 31 normal tension glaucoma patients demon-
strated cerebral blood ﬂow patterns similar to Alzheimer’s Diseaseeven though none were diagnosed with Alzheimer’s disease (Sug-
iyama et al., 2006). Visual ﬁeld defects progressed more rapidly
and cerebral blood ﬂow was lower in these patients. The effects
of a neuroprotective agent used to treat Alzheimer’s disease
(donepezil hydrochloride) were recently studied in this patient
population (Yoshida et al., 2010). All ﬁve patients demonstrated
signiﬁcant improvement on visual ﬁelds and measures of blood
ﬂow after only 6 months of treatment. These results suggest that
normal tension glaucoma is largely vascular in origin, and it may
Fig. 3. Visual ﬁeld data for all participants. CBF measurements and visual ﬁeld data from both eyes (OU) are presented. The three columns at left indicate the mean pattern
deviation (PDMEAN) for each test of visual function (SAP, SWAP and FDT). The gray scale and p-values demonstrate how the PDMEAN compares to the normative database. The
four columns at right present mean CBF (CBFMEAN) for each cortical region of interest (dorsal-left (DL), dorsal-right (DR), ventral-left (VL) and ventral-right (VR)). Yellowish-
red pixels correspond to voxels with large CBF values. Bluish-purple pixels indicate relatively smaller measurements of CBF. The axial slice with the highest mean CBF value is
presented for each region of interest, but data analysis was conducted on all active voxels. (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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ies and recent measurements of blood perfusion in the rat retina
using ASL implicate abnormal cerebral blow ﬂow in glaucoma (Li,
Cheng, & Duong, 2008; Shen et al., 2005).4.2. Measurements of cerebral metabolism using ASL fMRI
The calibrated BOLD technique is a non-invasive neuroimaging
protocol that compares ASL fMRI measurements of CBF and mea-
surements of the BOLD signal to obtain a quantitative estimate of
oxidative metabolism (CMRO2) (Davis et al., 1998; Hoge et al.,
1999). Hence, calibrated BOLDmay be the best method for measur-
ing CMRO2 changes in human glaucoma in vivo.We recently demonstrated that CMRO2 could be measured from
the LGN in healthy volunteers using physiological noise reduction
and background suppression methods (Lu et al., 2008). Background
suppression of fatty tissue enhances the SNR of the ASL fMRI signal.
The use of retrospective physiological noise reduction methods can
signiﬁcantly enhance the ASL signal in the visual cortex as well
(Restom, Behzadi, & Liu, 2006). However, we had difﬁculty imple-
menting the calibrated BOLD technique in the current experiment.
The addition of physiological measurement devices to the visual
display goggles and the claustrophobic MRI environment was too
challenging for our volunteers. Therefore, we decided to measure
resting CBF in the absence of visual stimulation as a means to infer
decreased cortical metabolism/function. Future modiﬁcations to
standard physiological measuring devices may make calibrated
Fig. 4. Comparisons between measurements of CBF and visual ﬁelds. Data points
represent visual ﬁeld asymmetry (DPDMEAN) and the difference in CBF for dorsal
and ventral V1 (DCBFMEAN). Large superior–inferior visual ﬁeld asymmetries were
accompanied by large ventral–dorsal CBF asymmetries and vice versa. A statistical
bootstrapping procedure showed the positive correlations for SAP (r = 0.49), SWAP
(r = 0.63), and FDT (r = 0.43) were signiﬁcant (all p < 0.05).
58 R.O. Duncan et al. / Vision Research 60 (2012) 51–60BOLD more feasible for use in patient populations. We are aware
that only the calibrated BOLD technique gives a true measure of
CRMO2.5. Conclusions
Resting blood perfusion in human V1 is correlated with the loss
of visual function in POAG. Altered CBF may be a contributing fac-
tor to glaucomatous optic neuropathy or it may be an indication of
post-retinal glaucomatous neurodegeneration caused by damage
to the retinal ganglion cells. In addition, the fMRI techniques devel-
oped in this report can be used to study human glaucoma in vivo
and may lead to new approaches for diagnosis and treatment. A
larger study of ocular hypertensive patients is required to deter-
mine whether compromised cerebral blood ﬂow predicts glauco-
matous neurodegeneration.6. Disclosure statement
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